Human iPSC-based tissue engineering system to develop salivary gland epithelial progenitors used to construct acinar organoids that mimic glandular microarchitecture and function.
Background:
Organoids are three-dimensional cell constructs that replicate the complicated tissue microarchitecture of specialized epithelial tissues. These constructs impart tissue function and allow their application to previous areas in which in vitro cells were not applicable, such as tissue engineering, drug testing and developmental biology. Here, salivary gland epithelial progenitors and acinar organoids are produced and provide a functional model for regenerative medicine and drug testing.
Technology Overview:
This University at Buffalo invention provides a novel differentiation technique that guides iPSC through the various glandular developmental stages with each progenitor lineage being induced via treatment with specific cocktails of growth factors, small molecules (agonist/inhibitors) and extracellular matrix (ECM) to mimic the developmental microenvironment necessary for the specific stage. This is also directed to the development of functional and biologically accurate acinar spheroids that express the correct mature markers in their specific cellular compartment along with the spheroids being polarized and lumenized to mimic the acinar phenotype in vivo, hence providing a platform for drug testing.
https://buffalo.technologypublisher.com/files/sites/7558_inpart_image.jpg
Source: JosLuis, https://stock.adobe.com/uk/613759231, stock.adobe.com
Advantages:
Applications:
Intellectual Property Summary:
US Provisional Patent Application 63/544,939 filed on October 19, 2023.
Stage of Development:
Laboratory demonstration through in vitro studies and analytical chemical analysis.
Licensing Status:
Available for licensing or collaboration.
Relevant Links: